Recce Pharmaceuticals up 6% on new antibiotic production milestone
Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
IIC | Ann:NTA 31 March 2024 | 11/04/24 | 0 | 92 | |||
|
|||||||
IIC | Ann:Half Yearly Report - 31 December 2023 (Price Sensitive) | 14/03/24 | 0 | 121 | |||
|
|||||||
IIC | Ann:NTA 29 February 2024 | 12/03/24 | 0 | 149 | |||
|
|||||||
IIC | Ann:Change in Director's Interest Notice - Steven Pritchar | 19/02/24 | 0 | 123 | |||
|
|||||||
IIC | Ann:NTA 31 January 2024 | 14/02/24 | 0 | 178 | |||
|
|||||||
IIC | Ann:Change in Director's Interests - Steven Pritchard | 31/01/24 | 0 | 114 | |||
|
|||||||
IIC | Ann:Change in Director's Interests - Steven Pritchard | 25/01/24 | 0 | 134 | |||
|
|||||||
IIC | Ann:NTA 31 December 2023 | 15/01/24 | 0 | 167 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |